These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2957374)

  • 21. The insulin receptor-related receptor. Tissue expression, ligand binding specificity, and signaling capabilities.
    Zhang B; Roth RA
    J Biol Chem; 1992 Sep; 267(26):18320-8. PubMed ID: 1326521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence that insulin plus ATP may induce a conformational change in the beta subunit of the insulin receptor without inducing receptor autophosphorylation.
    Maddux BA; Goldfine ID
    J Biol Chem; 1991 Apr; 266(11):6731-6. PubMed ID: 1849890
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two sequences flanking the major autophosphorylation site of the insulin receptor are essential for tyrosine kinase activation.
    Leconte I; Clauser E
    Biochem J; 1995 Mar; 306 ( Pt 2)(Pt 2):465-72. PubMed ID: 7887900
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Substitution of the insulin receptor transmembrane domain with the c-neu/erbB2 transmembrane domain constitutively activates the insulin receptor kinase in vitro.
    Yamada K; Goncalves E; Kahn CR; Shoelson SE
    J Biol Chem; 1992 Jun; 267(18):12452-61. PubMed ID: 1352286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin-induced egr-1 expression in Chinese hamster ovary cells is insulin receptor and insulin receptor substrate-1 phosphorylation-independent. Evidence of an alternative signal transduction pathway.
    Harada S; Smith RM; Smith JA; Shah N; Hu DQ; Jarett L
    J Biol Chem; 1995 Nov; 270(44):26632-8. PubMed ID: 7592888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Replacement of lysine residue 1030 in the putative ATP-binding region of the insulin receptor abolishes insulin- and antibody-stimulated glucose uptake and receptor kinase activity.
    Ebina Y; Araki E; Taira M; Shimada F; Mori M; Craik CS; Siddle K; Pierce SB; Roth RA; Rutter WJ
    Proc Natl Acad Sci U S A; 1987 Feb; 84(3):704-8. PubMed ID: 3101064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin-induced egr-1 and c-fos expression in 32D cells requires insulin receptor, Shc, and mitogen-activated protein kinase, but not insulin receptor substrate-1 and phosphatidylinositol 3-kinase activation.
    Harada S; Smith RM; Smith JA; White MF; Jarett L
    J Biol Chem; 1996 Nov; 271(47):30222-6. PubMed ID: 8939974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tyrosine kinase activity of a chimeric insulin-like-growth-factor-1 receptor containing the insulin receptor C-terminal domain. Comparison with the tyrosine kinase activities of the insulin and insulin-like-growth-factor-1 receptors using a cell-free system.
    Mothe I; Tartare S; Kowalski-Chauvel A; Kaliman P; Van Obberghen E; Ballotti R
    Eur J Biochem; 1995 Mar; 228(3):842-8. PubMed ID: 7737184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A mutant insulin receptor with defective tyrosine kinase displays no biologic activity and does not undergo endocytosis.
    McClain DA; Maegawa H; Lee J; Dull TJ; Ulrich A; Olefsky JM
    J Biol Chem; 1987 Oct; 262(30):14663-71. PubMed ID: 3312193
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytoplasmic juxtamembrane region of the insulin receptor: a critical role in ATP binding, endogenous substrate phosphorylation, and insulin-stimulated bioeffects in CHO cells.
    Backer JM; Schroeder GG; Cahill DA; Ullrich A; Siddle K; White MF
    Biochemistry; 1991 Jul; 30(26):6366-72. PubMed ID: 1647198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of insulin receptor kinase by multisite phosphorylation.
    Yu KT; Pessin JE; Czech MP
    Biochimie; 1985; 67(10-11):1081-93. PubMed ID: 3000458
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin signal transduction by a mutant human insulin receptor lacking the NPEY sequence. Evidence for an alternate mitogenic signaling pathway that is independent of Shc phosphorylation.
    Berhanu P; Anderson C; Hickman M; Ciaraldi TP
    J Biol Chem; 1997 Sep; 272(36):22884-90. PubMed ID: 9278451
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two naturally occurring mutant insulin receptors phosphorylate insulin receptor substrate-1 (IRS-1) but fail to mediate the biological effects of insulin. Evidence that IRS-1 phosphorylation is not sufficient for normal insulin action.
    Krook A; Moller DE; Dib K; O'Rahilly S
    J Biol Chem; 1996 Mar; 271(12):7134-40. PubMed ID: 8636149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutation of the two carboxyl-terminal tyrosines results in an insulin receptor with normal metabolic signaling but enhanced mitogenic signaling properties.
    Takata Y; Webster NJ; Olefsky JM
    J Biol Chem; 1991 May; 266(14):9135-9. PubMed ID: 2026614
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin-like growth factor receptors.
    Nissley SP; Haskell JF; Sasaki N; De Vroede MA; Rechler MM
    J Cell Sci Suppl; 1985; 3():39-51. PubMed ID: 3011825
    [TBL] [Abstract][Full Text] [Related]  

  • 36. C-terminus or juxtamembrane deletions in the insulin receptor do not affect the glucose-dependent inhibition of the tyrosine kinase activity.
    Mosthaf L; Berti L; Kellerer M; Mushack J; Seffer E; Bossenmaier B; Coghlan M; Siddle K; Ullrich A; Häring HU
    Eur J Biochem; 1995 Feb; 227(3):787-91. PubMed ID: 7867639
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decrease in the insulin receptor protein level by anti-insulin receptor antibodies: roles of tyrosine kinase activity and receptor internalization.
    Fujita N; Yamasaki H; Yamakawa K; Uotani S; Kuwahara H; Degawa-Yamauchi M; Abe T; Ozaki M; Sera Y; Kawasaki E; Takino H; Yamaguchi Y; Eguchi K
    Acta Diabetol; 2002 Dec; 39(4):221-7. PubMed ID: 12486497
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of monoclonal antibodies on human insulin receptor autophosphorylation, negative cooperativity, and down-regulation.
    Forsayeth JR; Montemurro A; Maddux BA; DePirro R; Goldfine ID
    J Biol Chem; 1987 Mar; 262(9):4134-40. PubMed ID: 2435731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Post-translational acquisition of ligand binding- and tyrosine kinase-domain function by the epidermal growth factor and insulin receptors.
    Lane MD; Slieker LJ; Olson TS; Martensen TM
    J Recept Res; 1987; 7(1-4):321-54. PubMed ID: 3305909
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NPXY motif in the insulin-like growth factor-I receptor is required for efficient ligand-mediated receptor internalization and biological signaling.
    Hsu D; Knudson PE; Zapf A; Rolband GC; Olefsky JM
    Endocrinology; 1994 Feb; 134(2):744-50. PubMed ID: 8299569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.